Business Wire

Axonics Acquires Technology to Facilitate Easier and Faster Placement of Implantable Leads for Sacral Neuromodulation

IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel ...
Nasdaq

Axonics Inc. (AXNX) Soars to 52-Week High, Time to Cash Out?

Have you been paying attention to shares of Axonics Modulation Technologies (AXNX)? Shares have been on the move with the stock up 6.1% over the past month. The stock hit a new 52-week high of $77.19 ...
Business Wire

Axonics Granted Four U.S. Patents Related to its Implantable Sacral Neuromodulation Technology

IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc., developer of the first rechargeable Sacral Neuromodulation (r-SNM™) system for the treatment of urinary and fecal dysfunction, ...
Business Insider

RBC Capital Keeps Their Buy Rating on Axonics Modulation Technologies (AXNX)

RBC Capital analyst Shagun Singh Chadha reiterated a Buy rating on Axonics Modulation Technologies (AXNX – Research Report) yesterday and set a price target of $69.00. The company’s shares closed ...